Back to search

A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus

Lupus Erythematosus, Systemic
Clinicaltrials.gov:
EU CTIS:
#2025-523552-31-00
Other:
#80202135SLE3001
Interested in this trial?
Subscribe or share this trial
Countries:
  • Argentina,
  • Brazil,
  • China,
  • Israel,
  • Japan,
  • Malaysia,
  • Taiwan,
  • Turkey (Türkiye),
  • United Kingdom,
  • United States
Loading...
Enrolling
Buenos Aires, Argentina, C1406AGA
Enrolling
Lake Charles, Louisiana, United States, 70605
Enrolling
La Palma, California, United States, 90623
Enrolling
Amarillo, Texas, United States, 79124
Enrolling
Ankara, Turkey (Türkiye), 06800
Enrolling
Ankara, Turkey (Türkiye), 06050
Enrolling
Ciudad de Buenos Aires, Argentina, C1427
Enrolling
Aventura, Florida, United States, 33180
Enrolling
Allen, Texas, United States, 75013
Enrolling
Hialeah, Florida, United States, 33013
Enrolling
Haifa, Israel, 3436212
Enrolling
Buenos Aires, Argentina, C1417EYG
Enrolling
Ciudad de Buenos Aires, Argentina, C1055
Enrolling
Philadelphia, Pennsylvania, United States, 19114
Enrolling
Tampa, Florida, United States, 33606
Enrolling
Clearwater, Florida, United States, 33765
Enrolling
Fayetteville, North Carolina, United States, 28304 4422
Enrolling
Charlotte, North Carolina, United States, 28211
Enrolling
Beverly Hills, California, United States, 90211
Enrolling
São Paulo, Brazil, 01232 010
Enrolling
Elâzığ, Turkey (Türkiye), 23200
Enrolling
Miami Lakes, Florida, United States, 33016
Enrolling
São José do Rio Preto, Brazil, 15090 000
Enrolling
Santo André, Brazil, 09060 870
Enrolling
Nahariya, Israel, 2210001
Enrolling
Jerusalem, Israel, 9112001
Enrolling
Stoke-on-Trent, United Kingdom, ST6 7AG
Enrolling
Porto Alegre, Brazil, 90035-903
Enrolling
Johor Bahru, Malaysia, 81100
Enrolling
Taiping, Malaysia, 34000
Enrolling
Kuching, Malaysia, 93586
Enrolling
Goiânia, Brazil, 74605-020
Enrolling
Upland, California, United States, 91786
Enrolling
Quilmes, Argentina, B1878GEG
Enrolling
Charlotte, North Carolina, United States, 28204
Enrolling
Kaohsiung City, Taiwan, 83301
Enrolling
Kaohsiung City, Taiwan, 813414
Enrolling
Porto Alegre, Brazil, 90480 000
Enrolling
Miami, Florida, United States, 33126
Enrolling
Linfen, China, 041000
Enrolling
Taoyuan, Taiwan, 333
Enrolling
San Fernando, Argentina, B1646GHP
Enrolling
Istanbul, Turkey (Türkiye), 34899
Enrolling
Kfar Saba, Israel, 4428164
Enrolling
Hsinchu, Taiwan, 302058
Enrolling
Konya, Turkey (Türkiye), 42080
Enrolling
Ningbo, China, 315041
Enrolling
Middleburg Heights, Ohio, United States, 44130
Enrolling
Beijing, China, 100044
Enrolling
Peterborough, United Kingdom, PE3 9GZ
Enrolling
Katy, Texas, United States, 77449
Enrolling
Haifa, Israel, 3109601
Enrolling
Gaziantep, Turkey (Türkiye), 27090
Enrolling
Taiyuan, China, 030032
Enrolling
Shanwei, China, 516601
Enrolling
Naha, Japan, 900 0015
Enrolling
Tustin, California, United States, 92780
Enrolling
Southampton, United Kingdom, SO16 6HU
Enrolling
Hemet, California, United States, 92543
Enrolling
Mesquite, Texas, United States, 75150
Enrolling
Tokyo, Japan, 104 8560
Enrolling
Petaling Jaya, Malaysia, 47500
Enrolling
Taipei, Taiwan, 11217
Enrolling
Tel Aviv, Israel, 6423906
Enrolling
Plano, Texas, United States, 75024
Enrolling
Isehara, Japan, 259-1193
Enrolling
Kuala Lumpur, Malaysia, 59100
Enrolling
Jackson, Tennessee, United States, 38305
Enrolling
Willowbrook, Illinois, United States, 60527
#
More than 50 sites in this region
#
More than 10 sites in this region
#
Less than 10 sites in this region
Map pin icon representing individual study sites
Individual sites
Access detailed information on the trial:
© Johnson & Johnson and its affiliates 2026
J&J Clinical Trials